KR101685187B1 - ３­카르복시프로필­아미노테트랄린 화합물의 결정형 - Google Patents

３­카르복시프로필­아미노테트랄린 화합물의 결정형 Download PDF

Info

Publication number
KR101685187B1
KR101685187B1 KR1020117015637A KR20117015637A KR101685187B1 KR 101685187 B1 KR101685187 B1 KR 101685187B1 KR 1020117015637 A KR1020117015637 A KR 1020117015637A KR 20117015637 A KR20117015637 A KR 20117015637A KR 101685187 B1 KR101685187 B1 KR 101685187B1
Authority
KR
South Korea
Prior art keywords
diethyl
methoxy
cyclohexylmethyl
carbamoyl
butyric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020117015637A
Other languages
English (en)
Korean (ko)
Other versions
KR20110093938A (ko
Inventor
션 달지엘
미로슬라브 라프타
Original Assignee
세라밴스 바이오파마 알앤디 아이피, 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 세라밴스 바이오파마 알앤디 아이피, 엘엘씨 filed Critical 세라밴스 바이오파마 알앤디 아이피, 엘엘씨
Publication of KR20110093938A publication Critical patent/KR20110093938A/ko
Application granted granted Critical
Publication of KR101685187B1 publication Critical patent/KR101685187B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/48—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C07C231/24—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020117015637A 2008-12-10 2009-12-09 ３­카르복시프로필­아미노테트랄린 화합물의 결정형 Expired - Fee Related KR101685187B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12125408P 2008-12-10 2008-12-10
US61/121,254 2008-12-10
PCT/US2009/067271 WO2010068649A1 (en) 2008-12-10 2009-12-09 Crystalline forms of a 3-carboxypropyl-aminotetralin compound

Publications (2)

Publication Number Publication Date
KR20110093938A KR20110093938A (ko) 2011-08-18
KR101685187B1 true KR101685187B1 (ko) 2016-12-09

Family

ID=42122774

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020117015637A Expired - Fee Related KR101685187B1 (ko) 2008-12-10 2009-12-09 ３­카르복시프로필­아미노테트랄린 화합물의 결정형

Country Status (21)

Country Link
US (4) US8101794B2 (enExample)
EP (1) EP2376427B1 (enExample)
JP (1) JP5650657B2 (enExample)
KR (1) KR101685187B1 (enExample)
CN (1) CN102245564B (enExample)
AR (1) AR074592A1 (enExample)
AU (1) AU2009324709B2 (enExample)
BR (1) BRPI0922920A2 (enExample)
CA (1) CA2745441C (enExample)
CL (1) CL2011001391A1 (enExample)
CO (1) CO6390054A2 (enExample)
ES (1) ES2645087T3 (enExample)
IL (1) IL213093A0 (enExample)
MX (1) MX2011006209A (enExample)
MY (1) MY179041A (enExample)
NZ (1) NZ593377A (enExample)
RU (1) RU2512390C2 (enExample)
SG (1) SG172016A1 (enExample)
TW (1) TWI449685B (enExample)
WO (1) WO2010068649A1 (enExample)
ZA (1) ZA201104319B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2402748T3 (es) 2007-12-11 2013-05-08 Theravance, Inc. Compuestos de aminotetralina como antagonistas del receptor de opioide mu
JP5403762B2 (ja) 2007-12-11 2014-01-29 セラヴァンス， インコーポレーテッド μオピオイド受容体アンタゴニストとしての３−カルボキシプロピル−アミノテトラリン誘導体
JP5797655B2 (ja) * 2009-09-18 2015-10-21 アドラー・コーポレーション 消化管障害のためのオピオイド受容体アンタゴニストの使用
JP2014528416A (ja) * 2011-09-30 2014-10-27 セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー ３−［２−メタンスルホニル−１−（４−トリフルオロメチル−フェノキシ）エチル］−ピロリジン化合物の結晶形態

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6844368B1 (en) * 1998-12-22 2005-01-18 Edward Roberts Compounds useful in pain management
US6498196B1 (en) * 1998-12-22 2002-12-24 Edward Roberts Compounds useful in pain management
US6231594B1 (en) 1999-08-11 2001-05-15 Radiant Medical, Inc. Method of controlling body temperature while reducing shivering
ATE533743T1 (de) * 2002-05-17 2011-12-15 Janssen Pharmaceutica Nv Harnstoffderivate von aminotetralin als modulatoren des vanilloid-rezeptors vr1
RU2005134364A (ru) * 2003-04-08 2006-06-10 Проджиникс Фармасьютикалз, Инк. (Us) Комбинированное лечение запора
SE0301794D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use III
CN101534827A (zh) 2006-11-07 2009-09-16 尼克塔治疗亚拉巴马公司 阿片样物质激动剂和阿片样物质拮抗剂的剂型和联合给药
EP1997493A1 (en) * 2007-05-28 2008-12-03 Laboratorios del Dr. Esteve S.A. Combination of a 5-HT7 receptor ligand and an opioid receptor ligand
ES2402748T3 (es) 2007-12-11 2013-05-08 Theravance, Inc. Compuestos de aminotetralina como antagonistas del receptor de opioide mu
JP5403762B2 (ja) 2007-12-11 2014-01-29 セラヴァンス， インコーポレーテッド μオピオイド受容体アンタゴニストとしての３−カルボキシプロピル−アミノテトラリン誘導体
EP2280933B1 (en) 2008-04-01 2013-07-24 Theravance, Inc. 2 -aminotetralin derivatives as mu opioid receptor antagonists

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
논문 Journal of Medicinal Chemistry, Vol. 47, No. 21 (2004)
논문 Tetrahedron: Asymmetry, Vol. 10, pp. 3769-3776 (1999)

Also Published As

Publication number Publication date
BRPI0922920A2 (pt) 2019-09-24
EP2376427A1 (en) 2011-10-19
MY179041A (en) 2020-10-26
AR074592A1 (es) 2011-01-26
US20100144881A1 (en) 2010-06-10
AU2009324709B2 (en) 2015-07-16
CA2745441C (en) 2017-10-17
CN102245564B (zh) 2015-04-01
WO2010068649A1 (en) 2010-06-17
US20130065916A1 (en) 2013-03-14
CN102245564A (zh) 2011-11-16
US8324236B2 (en) 2012-12-04
US8486958B2 (en) 2013-07-16
NZ593377A (en) 2013-07-26
US20130345466A1 (en) 2013-12-26
KR20110093938A (ko) 2011-08-18
RU2011128393A (ru) 2013-01-20
EP2376427B1 (en) 2017-08-02
US8969367B2 (en) 2015-03-03
ES2645087T3 (es) 2017-12-04
TWI449685B (zh) 2014-08-21
ZA201104319B (en) 2012-03-28
CO6390054A2 (es) 2012-02-29
US8101794B2 (en) 2012-01-24
JP5650657B2 (ja) 2015-01-07
AU2009324709A1 (en) 2011-06-30
RU2512390C2 (ru) 2014-04-10
CL2011001391A1 (es) 2011-11-11
MX2011006209A (es) 2011-07-12
US20120088834A1 (en) 2012-04-12
JP2012511580A (ja) 2012-05-24
SG172016A1 (en) 2011-07-28
TW201026646A (en) 2010-07-16
CA2745441A1 (en) 2010-06-17
IL213093A0 (en) 2011-07-31

Similar Documents

Publication Publication Date Title
US10426766B2 (en) Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
JP2010520198A5 (enExample)
KR101610165B1 (ko) 뮤 오피오이드 수용체 길항제로서의 3-카르복시프로필-아미노테트랄린 유도체
KR101685187B1 (ko) ３­카르복시프로필­아미노테트랄린 화합물의 결정형
EP2231589B1 (en) Aminotetralin compounds as mu opioid receptor antagonists
HK1139399B (en) Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

N231 Notification of change of applicant
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20191127

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20221206

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20221206